- Home
- DCTH vs STK Comparison
DCTH vs STK Comparison
Compare DCTH & STK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- STK
- Stock Information
- Founded
- DCTH 1988
- STK 2009
- Country
- DCTH United States
- STK United States
- Employees
- DCTH N/A
- STK N/A
- Industry
- DCTH Medical/Dental Instruments
- STK Investment Managers
- Sector
- DCTH Health Care
- STK Finance
- Exchange
- DCTH Nasdaq
- STK Nasdaq
- Market Cap
- DCTH 630.4M
- STK 434.6M
- IPO Year
- DCTH N/A
- STK N/A
- Fundamental
- Price
- DCTH $16.21
- STK $28.33
- Analyst Decision
- DCTH Strong Buy
- STK
- Analyst Count
- DCTH 4
- STK 0
- Target Price
- DCTH $24.00
- STK N/A
- AVG Volume (30 Days)
- DCTH 610.5K
- STK 38.2K
- Earning Date
- DCTH 05-08-2025
- STK 01-01-0001
- Dividend Yield
- DCTH N/A
- STK 6.60%
- EPS Growth
- DCTH N/A
- STK N/A
- EPS
- DCTH N/A
- STK N/A
- Revenue
- DCTH $53,850,000.00
- STK N/A
- Revenue This Year
- DCTH $141.47
- STK N/A
- Revenue Next Year
- DCTH $49.31
- STK N/A
- P/E Ratio
- DCTH N/A
- STK N/A
- Revenue Growth
- DCTH 1068.87
- STK N/A
- 52 Week Low
- DCTH $6.33
- STK $24.95
- 52 Week High
- DCTH $18.23
- STK $34.31
- Technical
- Relative Strength Index (RSI)
- DCTH 58.15
- STK 48.61
- Support Level
- DCTH $16.02
- STK $28.00
- Resistance Level
- DCTH $17.29
- STK $28.94
- Average True Range (ATR)
- DCTH 0.99
- STK 0.41
- MACD
- DCTH -0.03
- STK -0.10
- Stochastic Oscillator
- DCTH 49.63
- STK 16.92
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About STK Columbia Seligman Premium Technology Growth Fund Inc
Columbia Seligman Premium Technology Growth Fund Inc is a closed-end management investment company. Its investment objective is to seek growth of capital and current income. The fund invests in various sectors such as consumer discretionary, industrials, information technology and telecommunication services. Columbia Management Investment Advisers, LLC serves as the investment manager to the fund.